The Propaganda for Reform in Proprietary Medicines, Vol. 2 of 2
Free

The Propaganda for Reform in Proprietary Medicines, Vol. 2 of 2

By Various
Free
Book Description
Table of Contents
  • THE PROPAGANDA FOR REFORM IN Proprietary Medicines
  • PREFACE TO VOLUME 2
  • PREFACE TO VOLUME 1: NINTH EDITION
  • RESOLUTION ENDORSING THE WORK OF THE COUNCIL ON PHARMACY AND CHEMISTRY
    • Presented at the San Francisco Session and Signed by All the Members of the House of Delegates in Attendance
  • TABLE OF CONTENTS
  • PART I REPORTS OF THE COUNCIL ON PHARMACY AND CHEMISTRY
  • FOREWORD
    • THE COUNCIL ON PHARMACY AND CHEMISTRY
    • OFFICIAL RULES OF THE COUNCIL ON PHARMACY AND CHEMISTRY
      • Introduction
      • Rules Governing the Admission of Proprietary Articles to the Book New and Non­official Remedies
      • Explanatory Comments on the Rules
      • Explanation of Rule 1: Composition
      • Explanation of Rule 2: Identification
      • Explanation of Rule 3: Direct Advertising
      • Explanation of Rule 4: Indirect Advertising
      • Explanation of Rule 5: False Claims as to Origin
      • Explanation of Rule 6: Unwarranted Therapeutic Claims
      • Explanation of Rule 7: Poisonous Substances
      • Explanation of Rule 8: Objectionable Names
      • Explanation of Rule 9: Patents, Trademarks, Copyrights, Etc.
      • Explanation of Rule 10: Unscientific and Useless Articles
    • Introduction
    • Rules Governing the Admission of Proprietary Articles to the Book New and Non­official Remedies
    • Explanatory Comments on the Rules
    • Explanation of Rule 1: Composition
    • Explanation of Rule 2: Identification
    • Explanation of Rule 3: Direct Advertising
    • Explanation of Rule 4: Indirect Advertising
    • Explanation of Rule 5: False Claims as to Origin
    • Explanation of Rule 6: Unwarranted Therapeutic Claims
    • Explanation of Rule 7: Poisonous Substances
    • Explanation of Rule 8: Objectionable Names
    • Explanation of Rule 9: Patents, Trademarks, Copyrights, Etc.
    • Explanation of Rule 10: Unscientific and Useless Articles
    • THE COUNCIL ON PHARMACY AND CHEMISTRY, PRESENT AND FUTURE [A]
    • “ACCEPTED BY THE COUNCIL ON PHARMACY AND CHEMISTRY”
    • HELPING THE COUNCIL
    • DELAYS IN PASSING ON PRODUCTS
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • COOPERATION OF THE PHARMACEUTICAL HOUSES
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • BUDWELL’S EMULSION OF COD-LIVER OIL, NOS. 1 AND 2
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • RHEUMALGINE
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • GRAY’S GLYCERINE TONIC
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • TONGALINE AND PONCA COMPOUND
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • ALFATONE
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • ARTICLES REFUSED RECOGNITION
      • Report of the Council on Pharmacy and Chemistry
      • Uricsol
      • Jubol
      • Urodonal
    • Report of the Council on Pharmacy and Chemistry
    • Uricsol
    • Jubol
    • Urodonal
    • FORMAMINT
      • Report of the Council on Pharmacy and Chemistry
      • Experimental Data
      • Discussion
    • Report of the Council on Pharmacy and Chemistry
    • Experimental Data
    • Discussion
    • HYDRAGOGIN
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • FILUDINE
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • LACTOPEPTINE AND ELIXIR LACTOPEPTINE
      • Report of the Council on Pharmacy and Chemistry
      • Manufacturers’ Protest and Council’s Answer
      • Report of Referee A
      • Report of Referee B
    • Report of the Council on Pharmacy and Chemistry
    • Manufacturers’ Protest and Council’s Answer
    • Report of Referee A
    • Report of Referee B
    • IODUM-MILLER AND IOD-IZD-OIL (MILLER’S)
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • ELIXIR IODO-BROMIDE OF CALCIUM COMP. “WITHOUT MERCURY” AND “WITH MERCURY”
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • LECITHIN PREPARATIONS OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
      • Lecithin Preparations
    • Report of the Council on Pharmacy and Chemistry
    • Lecithin Preparations
    • PROPRIETARY NAMES FOR LIQUID PETROLATUM
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • SENG
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • FROSST’S BLAUD CAPSULES
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • TYREE’S ELIXIR OF BUCHU AND HYOSCYAMUS COMPOUND
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • HYDROLEINE
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • CURATIVE VACCINE, BRUSCHETTINI
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • STEARNS’ WINE
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • PROTONUCLEIN AND PROTONUCLEIN BETA
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • HYDROPSIN
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • DIGITALYSATUM
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • SO-CALLED SECRETIN PREPARATIONS
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • HAS SECRETIN A THERAPEUTIC VALUE? [B][C]
    • ARTICLES REFUSED RECOGNITION
      • Report of the Council on Pharmacy and Chemistry
      • Radio-Rem
      • Olio-Phlogosis
    • Report of the Council on Pharmacy and Chemistry
    • Radio-Rem
    • Olio-Phlogosis
    • THE HYPOPHOSPHITE FALLACY
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • PULVOIDS CALCYLATES
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • SULFURYL MONAL
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • MARK WHITE GOITER SERUM AND MARK WHITE IODINIZED OIL
      • Report of the Council on Pharmacy and Chemistry
      • Editorial Note on the Mark White “Serum”
    • Report of the Council on Pharmacy and Chemistry
    • Editorial Note on the Mark White “Serum”
    • KORA-KONIA
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • THE THERAPEUTIC VALUE OF THE GLYCEROPHOSPHATES
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • HYDRAS
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • BROMIN-IODIN COMPOUND
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • AMMONIUM HYPOPHOSPHITE OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • ALPHOZONE OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • CALCIUM GLYCEROPHOSPHATE AND SODIUM GLYCEROPHOSPHATE OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • GARDNER’S SYRUP OF AMMONIUM HYPOPHOSPHITE OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • GLUTEN PRODUCTS MADE BY THE KELLOGG FOOD COMPANY
      • Report of the Council on Pharmacy and Chemistry
      • Referee’s Report
    • Report of the Council on Pharmacy and Chemistry
    • Referee’s Report
    • IODO-MANGAN OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • LIQUID ALBOLENE
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • NAPHEY’S MEDICATED UTERINE WAFERS
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • NUJOL
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • PULVOIDS NATRIUM COMPOUND
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • SALOFORM
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • SECRETOGEN
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • IRON CITRATE GREEN
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • ASPIRIN
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • PIL. CASCARA COMPOUND-ROBINS
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • CASTA-FLORA
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • FIRWEIN
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • FIROLYPTOL PLAIN AND FIROLYPTOL WITH KREOSOTE
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • BINIODOL
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • COMPARATIVE SYMPTOMS RESULTING FROM THE USE OF SEVERAL OILY SUSPENSIONS OF RED MERCURIC IODID (MERCURY BINIODID)
      • Report of Dr. H. N. Cole[D]
      • Report of Dr. Albert Keidel
    • Report of Dr. H. N. Cole[D]
    • Report of Dr. Albert Keidel
    • CORPORA LUTEA (SOLUBLE EXTRACT), PARKE, DAVIS & CO.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • WHEELER’S TISSUE PHOSPHATES
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • WHEELER’S TISSUE PHOSPHATES
    • THE CLAIMED GALACTAGOGUE EFFECTS OF NUTROLACTIS AND GOAT’S RUE NOT SUBSTANTIATED
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • THE ALLEGED GALACTAGOGUE ACTION OF GALEGA AND NUTROLACTIS [E][F]
    • THE RUSSELL EMULSION AND THE RUSSELL PREPARED GREEN BONE
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • BROM-I-PHOS
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • CREOSOTE-DELSON AND CREOFOS
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • TRINER’S AMERICAN ELIXIR OF BITTER WINE
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • TRIMETHOL
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • FERRIVINE, INTRAMINE AND COLLOSOL IODINE
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • ESKAY’S NEURO PHOSPHATES
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • K-Y LUBRICATING JELLY
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • ZIRATOL
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • GONOSAN
      • Report of the Council on Pharmacy and Chemistry
      • Appendix
    • Report of the Council on Pharmacy and Chemistry
    • Appendix
    • ALCRESTA IPECAC
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • IODEOL AND IODAGOL
      • Report of the Council on Pharmacy and Chemistry
      • Summary of Referee’s Report
    • Report of the Council on Pharmacy and Chemistry
    • Summary of Referee’s Report
    • CAPSULES BISMUTH RESORCINOL COMPOUND NOT ADMITTED TO N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • DIXON’S TUBERCLE BACILLI EXTRACT AND DIXON’S SUSPENSION OF DEAD TUBERCLE BACILLI
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • FORMOSOL
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • IODOLENE, A SOLUTION OF IODIN IN LIQUID PETROLATUM, INADMISSIBLE TO N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • KALAK WATER
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • MINSON’S SOLUBLE IODIN “KELPIDINE” NOT ADMITTED TO N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • NUTONE
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • TRI-ARSENOLE, L. O. COMPOUND NO. 1 AND L. O. COMPOUND NO. 2
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • UNCTOL
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • V-E-M (SCHOONMAKER LABORATORIES, INC.)
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • HEMO-THERAPIN
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • VENOSAL
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • SECRETIN-BEVERIDGE AND THE U. S. PATENT LAW
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • THE QUESTION OF THE STABILITY OF SECRETIN
    • NEED FOR PATENT LAW REVISION
      • Report of the Committee on Patent-Law Revision of the Council on Pharmacy and Chemistry of the American Medical Association
    • Report of the Committee on Patent-Law Revision of the Council on Pharmacy and Chemistry of the American Medical Association
    • SURGODINE
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • MEDEOL SUPPOSITORIES
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • GUAIODINE
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • SEVERAL “MIXED” VACCINES NOT ADMITTED TO N. N. R.
      • Report of the Council on Pharmacy and Chemistry
      • Mixed Vaccines-Abbott
      • Catarrhal Vaccine Combined-Lilly and Influenza Mixed Vaccine-Lilly
      • Influenza Serobacterin Mixed-Mulford
      • Sherman’s Mixed Vaccine No. 40
    • Report of the Council on Pharmacy and Chemistry
    • Mixed Vaccines-Abbott
    • Catarrhal Vaccine Combined-Lilly and Influenza Mixed Vaccine-Lilly
    • Influenza Serobacterin Mixed-Mulford
    • Sherman’s Mixed Vaccine No. 40
    • OPHTHALMOL-LINDEMANN
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • SILVOL INELIGIBLE FOR N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • KATHARMON
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • IODINIZED EMULSION (SCOTT) AND CREOSOTONIC (SCOTT)
      • Report of the Council on Pharmacy and Chemistry
      • Iodinized Emulsion (Scott)
      • Creosotonic (Scott)
    • Report of the Council on Pharmacy and Chemistry
    • Iodinized Emulsion (Scott)
    • Creosotonic (Scott)
    • CAMPETRODIN AND CAMPETRODIN NO. 2
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • CARMINZYM
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • PHILLIPS’ PHOSPHO-MURIATE OF QUININE COMP.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • B. IODINE AND B. OLEUM IODINE
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • B. IODINE PRODUCTS
    • ANTITHYROID PREPARATIONS (ANTITHYROIDIN-MOEBIUS AND THYREOIDECTIN) OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • CEPHAELIN AND SYRUP CEPHAELIN-LILLY OMITTED FROM N. N. R. AND SYRUP EMETIC-LILLY NOT ACCEPTED
      • Report of Council on Pharmacy and Chemistry
    • Report of Council on Pharmacy and Chemistry
    • COLALIN OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • FORAL
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • GRANULAR EFFERVESCENT BROMIDE AND ACETANILID COMPOUND-MULFORD
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • HOLADIN AND BILE SALT MIXTURES
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • LIQUOR SANTAIVA, S. & D., OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • MALTZYME, MALTZYME WITH CASCARA SAGRADA, MALTZYME WITH COD LIVER OIL, MALTZYME FERRATED AND MALTZYME WITH YERBA SANTA OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • METHAFORM OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • PINEAL GLAND, RED BONE-MARROW AND THYMUS GLAND AND THEIR PREPARATIONS OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
      • Pineal Gland
      • Red Bone-Marrow
      • Thymus Gland
    • Report of the Council on Pharmacy and Chemistry
    • Pineal Gland
    • Red Bone-Marrow
    • Thymus Gland
    • PIPERAZINE AND LYCETOL OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • STANOLIND LIQUID PARAFFIN OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • WESTERFIELD’S DIGITALIS TABLETS
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • XEROFORM-HEYDEN AND BISMUTH TRI­BROM­PHENATE-MERCK OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • CREAM OF MUSTARD REFUSED RECOGNITION
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • “PLURIGLANDULAR” MIXTURES
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • CERELENE NOT ADMITTED TO N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • COLLOSOL COCAINE NOT ADMITTED TO N. N. R
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • CUPRASE NOT ADMITTED TO N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • COLLOSOL PREPARATIONS
      • Report of the Council on Pharmacy and Chemistry
      • Additional Notes on Collosol Evidence
    • Report of the Council on Pharmacy and Chemistry
    • Additional Notes on Collosol Evidence
    • PULVOIDS CALCYLATES COMPOUND
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • PROTEOGENS OF THE WM. S. MERRELL COMPANY
      • Report of the Council on Pharmacy and Chemistry
      • Report of First Referee on Proteogens
      • Report of Second Referee Reviewing Manufacturers’ Reply
    • Report of the Council on Pharmacy and Chemistry
    • Report of First Referee on Proteogens
    • Report of Second Referee Reviewing Manufacturers’ Reply
    • “ARSENOVEN S. S.” AND “ARSENO-METH-HYD”
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • HORMOTONE AND HORMOTONE WITHOUT POST-PITUITARY
      • Report of the Council on Pharmacy and Chemistry.
    • Report of the Council on Pharmacy and Chemistry.
    • FORMALDEHYDE LOZENGES
      • Report of the Council on Pharmacy and Chemistry
      • Hex-Iodin
      • Formitol Tablets
      • Cin-U-Form Lozenges
    • Report of the Council on Pharmacy and Chemistry
    • Hex-Iodin
    • Formitol Tablets
    • Cin-U-Form Lozenges
    • LAVORIS
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • MEDINAL
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • OMISSION OF COTARNIN SALTS (STYPTICIN AND STYPTOL) FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • MICAJAH’S WAFERS AND MICAJAH’S SUPPOSITORIES
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • ALKALITHIA
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • ARHOVIN OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • CHLORON, CHLORAX AND NUMBER “3”
      • Report of the Council on Pharmacy and Chemistry
      • Chloron
      • Chlorax
      • Number “3”
    • Report of the Council on Pharmacy and Chemistry
    • Chloron
    • Chlorax
    • Number “3”
    • ELARSON OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • IODIPHOS
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • MERVENOL AND ARMERVENOL NOT ADMITTED TO N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • NORMAL PHENOL SERUM (CANO) AND METHYL-PHENOL SERUM (CANO) NOT ACCEPTED FOR N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • SOAMIN OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • SOME MIXED VACCINES NOT ADMITTED TO N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • SOMNOFORM
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • TABLETS FORMOTHALATES
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • TRIPLE ARSENATES WITH NUCLEIN
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • “ANTI-PNEUMOCOCCIC OIL” AND THE USE OF CAMPHOR IN PNEUMONIA
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • DIAL “CIBA”
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • APOTHESINE
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • EUMICTINE
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • PLATT’S CHLORIDES
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • ANTI-TUBERCULOUS LYMPH COMPOUND (SWEENY) AND ANTI-SYPHILITIC COMPOUND (SWEENY)
      • Report of the Council on Pharmacy and Chemistry
      • Anti-Tuberculous Lymph Compound (Sweeny)
      • Anti-Syphilitic Compound (Sweeny)
    • Report of the Council on Pharmacy and Chemistry
    • Anti-Tuberculous Lymph Compound (Sweeny)
    • Anti-Syphilitic Compound (Sweeny)
    • SYRUP LEPTINOL (FORMERLY SYRUP BALSAMEA)
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • FORMITOL TABLETS, II
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • SUKRO-SERUM AND APHLEGMATOL
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • SUPSALVS NOT ADMITTED TO N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • HYPODERMIC SOLUTION NO. 13, IRON, ARSENIC AND PHOSPHORUS COMPOUND NOT ACCEPTED FOR N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • PARATHESIN NOT ADMITTED TO N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • CHLORLYPTUS
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • I. DETAILED REPORTS
      • Summarized Reports
    • Summarized Reports
    • II. APPENDIX: SPECIAL REPORTS
    • A. COMPARISON OF CHLORLYPTUS WITH CHLORINATED EUCALYPTOL
      • From the Chemical Laboratory of the American Medical Association
    • From the Chemical Laboratory of the American Medical Association
    • B. THE PERSISTENCE OF THE ACID
      • Reaction of Chlorlyptus in the Body
    • Reaction of Chlorlyptus in the Body
    • C. TOXICITY EXPERIMENTS
    • D. REPORT OF DR. D. RIVAS
    • AQUAZONE (OXYGEN WATER)
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • COAGULEN-CIBA OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • FERRIC CACODYLATE OMITTED FROM NEW AND NONOFFICIAL REMEDIES
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • LIBRADOL
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • HELMITOL OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • SPIROCIDE NOT ADMITTED TO N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • DIGIFOLIN-CIBA NOT ADMITTED TO N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • SOME OF LOESER’S INTRAVENOUS SOLUTIONS
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • “NATIONAL IODINE SOLUTION” NOT ADMITTED TO N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • MON-ARSONE NOT ADMITTED TO N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • OXYL-IODIDE NOT ADMITTED TO N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • QUASSIA COMPOUND TABLETS
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • TOXICIDE
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • PIL. MIXED TREATMENT (CHICHESTER)
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • ATOPHAN OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • UROTROPIN OMITTED FROM N. N. R.
      • Report of the Council on Pharmacy and Chemistry
      • Commercial History of Hexamethylenamin
      • Urotropin Marketed Under Unwarranted Therapeutic Claims
      • Urotropin a Brand of Hexamethylenamine, U. S. P.
    • Report of the Council on Pharmacy and Chemistry
    • Commercial History of Hexamethylenamin
    • Urotropin Marketed Under Unwarranted Therapeutic Claims
    • Urotropin a Brand of Hexamethylenamine, U. S. P.
    • STYPTYSATE NOT ADMITTED TO N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • LIPOIDAL SUBSTANCES (HOROVITZ) NOT ADMITTED TO N. N. R.
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
    • YEAST PREPARATIONS AND VITAMIN B CONCENTRATES
      • Report of the Council on Pharmacy and Chemistry
    • Report of the Council on Pharmacy and Chemistry
  • PART II CONTRIBUTIONS FROM THE A. M. A. CHEMICAL LABORATORY
  • FOREWORD
    • THE CHEMICAL LABORATORY OF THE AMERICAN MEDICAL ASSOCIATION
    • THE WORK OF THE AMERICAN MEDICAL ASSOCIATION CHEMICAL LABORATORY[G]
    • LEAD IN “AKOZ”
      • Details of Analysis
    • Details of Analysis
    • SODIUM ACETATE IN WARMING BOTTLES
    • ANTI-SYPHILITIC COMPOUND (SWEENY)
    • “AMBRINE” AND PARAFFIN FILMS[H]
      • Addenda
    • Addenda
    • THE STABILITY OF IODINE OINTMENTS
    • IODOLENE AND THE SOLUBILITY OF IODIN IN LIQUID PETROLATUM
    • AMERICAN-MADE SYNTHETIC DRUGS—I
      • Examination of American-Made Acetylsalicylic Acid
    • Examination of American-Made Acetylsalicylic Acid
    • THE STANDARDIZATION OF COMMERCIAL BISMUTH TRIBROMPHENATE
      • Report to Council of National Defense
      • Revision of N. N. R. Standards
    • Report to Council of National Defense
    • Revision of N. N. R. Standards
    • THE STANDARDIZATION OF PROCAIN AND EXAMINATION OF THE MARKET SUPPLY
    • DETERIORATION OF SODIUM HYPOCHLORITE SOLUTIONS (“Chlorinated Soda” Solutions)
    • SYPHILODOL
      • Details of Analysis
    • Details of Analysis
    • CERELENE
    • DR. DE SANCTIS’ RHEUMATIC AND GOUT PILLS
    • IODEX AND LIQUID IODEX
      • Details of Analysis
    • Details of Analysis
    • I. G. O.
    • IODIN IN LIQUID PETROLATUM
    • AMERICAN-MADE SYNTHETIC DRUGS—II
      • Examination of Procain (Novocain), Barbital (Veronal), Phenetidyl-Acetphenetidin (Holocain), Cinchophen or Phenyl­cinchoninic Acid (Atophan), Manufactured Under Federal Trade Commission Licenses[I][J]
    • Examination of Procain (Novocain), Barbital (Veronal), Phenetidyl-Acetphenetidin (Holocain), Cinchophen or Phenyl­cinchoninic Acid (Atophan), Manufactured Under Federal Trade Commission Licenses[I][J]
  • PART III CONTRIBUTIONS FROM THE JOURNAL: PROPRIETARY PRODUCTS
    • NOSTRUMS IN RETROSPECT
      • A Series of Nine Articles Reviewing Worthless or Unscientific Proprietary Mixtures Previously Criticized
    • A Series of Nine Articles Reviewing Worthless or Unscientific Proprietary Mixtures Previously Criticized
    • [Article I]
      • Bell-Ans (Pa-Pay-Ans Bell)[K]
    • Bell-Ans (Pa-Pay-Ans Bell)[K]
    • [Article II]
      • Anasarcin and Anedemin
    • Anasarcin and Anedemin
    • [Article III]
      • Pepto-Mangan
    • Pepto-Mangan
    • [Article IV]
      • Cactina Pillets
    • Cactina Pillets
    • [Article V]
      • Ammonol and Phenalgin
    • Ammonol and Phenalgin
    • [Article VI]
      • Fellows’ Syrup, and Other Preparations of the Hypo­phosphites
    • Fellows’ Syrup, and Other Preparations of the Hypo­phosphites
    • [Article VII]
      • Shotgun Nostrums
    • Shotgun Nostrums
    • [Article VIII]
      • Tyree’s Antiseptic and Aseptinol
    • Tyree’s Antiseptic and Aseptinol
    • [Article IX]
      • Neurosine and the Original Package Evil
    • Neurosine and the Original Package Evil
    • ANASARCIN ADVERTISING[L]
    • ANTIMERISTEM-SCHMIDT
    • ANTIPHLOGISTINE
    • “AUTO-HEMIC SERUM”
      • A Cure for Laziness, Ugliness, Frigidity and Many Other Things
    • A Cure for Laziness, Ugliness, Frigidity and Many Other Things
    • “AUTOLYSIN” ADVERTISING
    • “BASIC CANCER RESEARCH” AND “COSMOPOLITAN CANCER RESEARCH SOCIETY”
      • Seleni-Bascca
      • Repudiated by the Brooklyn Bureau of Charities
    • Seleni-Bascca
    • Repudiated by the Brooklyn Bureau of Charities
    • BELL-ANS (PAPAYANS, BELL)[M]
      • As the New York Tribune’s “Ad-Visor” Sees It
    • As the New York Tribune’s “Ad-Visor” Sees It
    • CAMPHO-PHENIQUE
      • Appealing to the New Fledged Graduate.
    • Appealing to the New Fledged Graduate.
    • “CINCHOPHEN”: FORMERLY “ATOPHAN”
    • “COLLOSOLS”: AN UNCRITICAL ENGLISH ENDORSEMENT
      • Collosol Manganese
    • Collosol Manganese
    • COTTON PROCESS ETHER
      • A Note from the Manufacturers
    • A Note from the Manufacturers
    • DIONOL
      • Glorified Petrolatum
    • Glorified Petrolatum
    • THE ELI PRODUCTS OF ELI H. DUNN
    • GLOVER’S CANCER SERUM
      • The Toronto Academy of Medicine Reports Unfavorably on Glover’s Cancer Serum
    • The Toronto Academy of Medicine Reports Unfavorably on Glover’s Cancer Serum
    • GLYCO-THYMOLINE AND POLIOMYELITIS
    • GLYKERON: COLD STORAGE TESTIMONIALS [N]
    • GRAY’S GLYCERINE TONIC: “WHOSE BREAD I EAT HIS SONG I SING”
    • HAGEE’S CORDIAL OF COD LIVER OIL
    • HYPNO-BROMIC COMPOUND
    • INTRAVENOUS COMPOUND (LOFFLER)
      • Its Composition and the Peculiar Methods by Which It Is Exploited
    • Its Composition and the Peculiar Methods by Which It Is Exploited
    • INTRAVENOUS SPECIALTIES
    • IODEX
    • THE WILLIAM F. KOCH CANCER REMEDY
      • Further Comment
    • Further Comment
    • THE LUCAS LABORATORIES’ PRODUCTS
    • “PHYLACOGENS” [O]
    • PINEOLEUM ADVERTISING METHODS
      • Capitalizing the Name and Position of the President of the American Medical Association
    • Capitalizing the Name and Position of the President of the American Medical Association
    • “PROTEAL THERAPY” AND HENRY SMITH WILLIAMS
    • PROTEOGENS
      • Commercial Therapeutics [P]
      • An Alleged Endorsement of Proteogens Repudiated
      • The Manufacturer’s Protest and a Reply
      • Details of the Alleged Endorsement of Proteogens
      • Dr. Broeman’s Final Report on Proteogens
    • Commercial Therapeutics [P]
    • An Alleged Endorsement of Proteogens Repudiated
    • The Manufacturer’s Protest and a Reply
    • Details of the Alleged Endorsement of Proteogens
    • Dr. Broeman’s Final Report on Proteogens
    • PULVANE
    • SAL HEPATICA
    • SALICON
    • SO-CALLED SECRETIN PREPARATIONS
    • SUCCUS CINERARIA MARITIMA
      • Another Illustration of One of the Weaknesses of the Federal Food and Drugs Act
    • Another Illustration of One of the Weaknesses of the Federal Food and Drugs Act
    • TEKARKIN
      • Edward Percy Robinson’s “Cure” for Cancer
    • Edward Percy Robinson’s “Cure” for Cancer
    • TYREE’S ANTISEPTIC POWDER AGAIN
      • The “Ethical and Commercial Requirements” of the Drug Business
    • The “Ethical and Commercial Requirements” of the Drug Business
    • WHEELER’S TISSUE PHOSPHATES
    • BRIEFER PARAGRAPHS
      • Alcresta Lotion
      • Calcidin Tablets (Abbott)
      • Di-Crotalin Treatment of Epilepsy
      • Estivin
      • Iron Arsenite
      • K-Y Lubricating Jelly
      • “Nikalgin”
      • Pertussin and Syrup of Thyme
      • Quinin and Urea Hydrochlorid
      • Ricord Pills and House Organ Therapeutics
      • Stannoxyl
      • Syphilodol
      • Thialion
    • Alcresta Lotion
    • Calcidin Tablets (Abbott)
    • Di-Crotalin Treatment of Epilepsy
    • Estivin
    • Iron Arsenite
    • K-Y Lubricating Jelly
    • “Nikalgin”
    • Pertussin and Syrup of Thyme
    • Quinin and Urea Hydrochlorid
    • Ricord Pills and House Organ Therapeutics
    • Stannoxyl
    • Syphilodol
    • Thialion
  • PART IV CONTRIBUTIONS FROM THE JOURNAL: MISCELLANY
    • ALBERT ABRAMS, A.M., M.D., LL.D., F.R.M.S.
      • “Spondylo­therapy,” “Electronic Reactions,” the “Oscilloclast,” the “Electrobioscope,” Etc.
      • Dr. Abrams’ Graduation
      • A Defense by Upton Sinclair
      • Comment
    • “Spondylo­therapy,” “Electronic Reactions,” the “Oscilloclast,” the “Electrobioscope,” Etc.
    • Dr. Abrams’ Graduation
    • A Defense by Upton Sinclair
    • Comment
    • ACETYLSALICYLIC ACID, NOT ASPIRIN
      • “What’s in a Name?”
      • Advertising Principles—Lay and Medical
      • “Aspirin”—A Common Name
      • “Aspirin Bayer” and the Sterling Products Company
    • “What’s in a Name?”
    • Advertising Principles—Lay and Medical
    • “Aspirin”—A Common Name
    • “Aspirin Bayer” and the Sterling Products Company
    • THE ALLIED MEDICAL ASSOCIATIONS OF AMERICA
      • Another Rocket in the Pyrotechnics of Quasimedical Organizations
    • Another Rocket in the Pyrotechnics of Quasimedical Organizations
    • “ARSENICALS”
      • Pharmacology of Arsenicals
      • Salvarsan: Abrogate the Patent
      • End the Monopoly
      • Arsphenamin
    • Pharmacology of Arsenicals
    • Salvarsan: Abrogate the Patent
    • End the Monopoly
    • Arsphenamin
    • BEER AND CANCER CURES
      • Did the Brewing Interests Advertise Autolysin?
    • Did the Brewing Interests Advertise Autolysin?
    • BIOLOGIC THERAPEUTICS AND ITS COMMERCIAL DOMINATION
    • CAPELL’S UROLUETIC TEST
      • Another Urinary Test for Syphilis
    • Another Urinary Test for Syphilis
    • CHEMOTHERAPY AND TUMORS [Q][R]
      • Richard Weil, M.D., New York
    • Richard Weil, M.D., New York
    • THE DIRECT SALES COMPANY
    • DISCOVERIES AND DISCOVERERS
    • “DRUG REFORM”
      • As It Appears to the Cleveland Medical Journal
    • As It Appears to the Cleveland Medical Journal
    • DRUG THERAPY: THE FALLIBILITY OF TEXTBOOKS
    • THOMAS WEBSTER EDGAR
      • Tired Rabbits for Diabetes; Ring-Tailed Monkeys for Sex Stimulation
      • The Journal Receives a Letter Denouncing “Medical Clerks” and “Biased Sceptres”
    • Tired Rabbits for Diabetes; Ring-Tailed Monkeys for Sex Stimulation
    • The Journal Receives a Letter Denouncing “Medical Clerks” and “Biased Sceptres”
    • GLYCEROPHOSPHATES
    • INFLUENZA VACCINES
      • Serums and Vaccines
    • Serums and Vaccines
    • INTRAVENOUS THERAPY
    • IODIN FUMES
    • ITALIAN PHYSICO-CHEMICAL COMPANY
    • WHAT IS LIQUID PETROLATUM?
    • THE LOWENTHAL POSTGRADUATE COURSE
      • Which Tells How to Make Diagnoses Accurately, Scientifically Check the Christian Scientists and Increase Your Earning Power
    • Which Tells How to Make Diagnoses Accurately, Scientifically Check the Christian Scientists and Increase Your Earning Power
    • MEDICAL SOCIETY OF THE UNITED STATES
      • From “Division of Fees” to “Down with Autocracy”
    • From “Division of Fees” to “Down with Autocracy”
    • THE NATIONAL FORMULARY—A REVIEW OF THE FOURTH EDITION
    • NONSPECIFIC PROTEIN THERAPY
    • WILLARD EALON OGDEN
      • A “Specialist in Proctology” and His “Clinics”
    • A “Specialist in Proctology” and His “Clinics”
    • “PATENTS”
      • Patent Laws and Patent Office Practice
      • Our Archaic Patent Laws
      • Patents Perpetuated by Trade Names
      • Patenting Therapeutic Agents
    • Patent Laws and Patent Office Practice
    • Our Archaic Patent Laws
    • Patents Perpetuated by Trade Names
    • Patenting Therapeutic Agents
    • PHARMACEUTICAL BARNUMS
    • THE PHARMACOPEIA
      • The Ninth Decennial Revision
      • Review of Ninth Revision
    • The Ninth Decennial Revision
    • Review of Ninth Revision
    • PHYSICIAN’S STOCK IN PRESCRIPTION PRODUCTS
    • PITUITARY GLAND PREPARATIONS
    • PROPRIETORSHIP IN MEDICINE
      • The Manufacturer’s Protest
      • Why Proprietaries Flourish
    • The Manufacturer’s Protest
    • Why Proprietaries Flourish
    • PHILIP RAHTJEN AND HIS DISCOVERIES
    • SODIUM CACODYLATE IN SYPHILIS
    • TABLETS: DEPENDABILITY OF DOSAGE
    • THERAPEUTIC EVIDENCE: ITS CRUCIAL TEST [S][T]
      • Torald Sollmann, M.D., Cleveland
    • Torald Sollmann, M.D., Cleveland
    • “VACCINES IN TOXIC CONDITIONS”
      • Commercialized Propaganda in the Guise of Science
    • Commercialized Propaganda in the Guise of Science
    • VITAMINS: THEIR DISTRIBUTION
      • Our Knowledge of Vitamins
      • The Demand for Vitamins
    • Our Knowledge of Vitamins
    • The Demand for Vitamins
    • THE WILLIAM A. WEBSTER CO. AND THE DIRECT PHARMACEUTICAL CO.
    • YEAST
      • Yeast and Its Uses
    • Yeast and Its Uses
    • BRIEFER PARAGRAPHS
      • Laxol and Lysol—The Short and Catchy Proprietary Name
      • Look Up Its Rating
      • The Medical Profession and Commercial Interests
      • Rabbit-Foot Therapy
      • Secret Remedies and the Principles of Ethics
      • “Sterling Violet Ray Generator”
      • Strontium Salicylate Not Superior to Sodium Salicylate
      • Vaccine As a Prophylactic in Influenza
      • Vaccines for “Colds”
    • Laxol and Lysol—The Short and Catchy Proprietary Name
    • Look Up Its Rating
    • The Medical Profession and Commercial Interests
    • Rabbit-Foot Therapy
    • Secret Remedies and the Principles of Ethics
    • “Sterling Violet Ray Generator”
    • Strontium Salicylate Not Superior to Sodium Salicylate
    • Vaccine As a Prophylactic in Influenza
    • Vaccines for “Colds”
  • INDEX AND BIBLIOGRAPHY
  • FOOTNOTES:
    No review for this book yet, be the first to review.
      No comment for this book yet, be the first to comment
      You May Also Like
      Also Available On
      App store smallGoogle play small
      Categories
      Curated Lists
      • Pattern Recognition and Machine Learning (Information Science and Statistics)
        by Christopher M. Bishop
        Data mining
        by I. H. Witten
        The Elements of Statistical Learning: Data Mining, Inference, and Prediction
        by Various
        See more...
      • CK-12 Chemistry
        by Various
        Concept Development Studies in Chemistry
        by John Hutchinson
        An Introduction to Chemistry - Atoms First
        by Mark Bishop
        See more...
      • Microsoft Word - How to Use Advanced Algebra II.doc
        by Jonathan Emmons
        Advanced Algebra II: Activities and Homework
        by Kenny Felder
        de2de
        by
        See more...
      • The Sun Who Lost His Way
        by
        Tania is a Detective
        by Kanika G
        Firenze_s-Light
        by
        See more...
      • Java 3D Programming
        by Daniel Selman
        The Java EE 6 Tutorial
        by Oracle Corporation
        JavaKid811
        by
        See more...